Merck, Pfizer settle patent dispute over pneumococcal vaccine
New Delhi: Merck Sharp & Dohme Corp and Pfizer's Wyeth LLC subsidiary have resolved a patent dispute over their competing vaccines for preventing diseases including pneumonia and meningitis, according to a Delaware court filing.
The parties asked U.S. District Judge Richard Andrews on Tuesday to dismiss the claims with prejudice. Pfizer spokesperson Pam Eisele said in an email on Wednesday that the companies had resolved their worldwide dispute over the vaccine patents. Details of the settlement weren't immediately available.
Kenilworth, N.J.-based Merck had requested a declaratory judgment from the court in January that its Vaxneuvance vaccine for diseases caused by pneumococcus bacteria, which the U.S. Food and Drug Administration approved in July, didn't infringe three patents related to Wyeth's Prevnar vaccines. Merck's complaint said it and New York-based Wyeth had been embroiled in patent proceedings related to the vaccines for over four years in several countries including Australia, Canada, Japan, and the UK.
Merck and its attorneys Anthony Insogna of Jones Day and John Day of Ashby & Geddes didn't immediately respond to a request for comment. Merck attorney Arlene Chow of Latham & Watkins declined to comment.
Wyeth's attorneys Dimitrios Drivas of White & Case and Arthur Connolly of Connolly Gallagher didn't immediately respond to a request for comment.
Merck said in its complaint that it was suing to "clear the way" to deliver its vaccine in the U.S. by "lifting the threat of an imminent lawsuit by Wyeth." Wyeth later countersued Merck for allegedly infringing the Prevnar patents.
The complaint said Merck's vaccine was the first "real alternative" to Wyeth's Prevnar conjugate pneumonia vaccines in the U.S. Conjugate vaccines create a stronger immune response than earlier vaccines.
The case is Merck Sharp & Dohme Corp v. Wyeth LLC, U.S. District Court for the District of Delaware, No. 1:21-cv-00024.
Read also: Pfizer expands recall of Chantix over presence of cancer causing agents
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.